HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrick Marcellin Selected Research

faldaprevir

2/2014HCV direct-acting antiviral agents: the best interferon-free combinations.
2/2014Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrick Marcellin Research Topics

Disease

89Chronic Hepatitis B
08/2023 - 01/2002
80Infections
08/2023 - 08/2002
79Fibrosis (Cirrhosis)
08/2023 - 01/2002
65Chronic Hepatitis C
10/2020 - 01/2002
31Hepatitis C
01/2022 - 01/2002
16Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 01/2005
15Liver Diseases (Liver Disease)
01/2021 - 01/2002
14Hepatitis B
04/2023 - 08/2002
14Hepatocellular Carcinoma (Hepatoma)
01/2020 - 08/2006
10Virus Diseases (Viral Diseases)
06/2015 - 06/2004
8Viremia
01/2021 - 06/2004
6Chronic Hepatitis (Chronic Active Hepatitis)
01/2021 - 09/2006
6Insulin Resistance
10/2012 - 08/2007
5Hepatitis
01/2022 - 04/2003
5Persistent Infection
01/2021 - 06/2004
5Coinfection
01/2019 - 07/2004
5Inflammation (Inflammations)
11/2016 - 01/2002
3Headache (Headaches)
10/2020 - 09/2004
3Fatigue
10/2020 - 09/2004
3End Stage Liver Disease
01/2020 - 11/2006
3Anemia
06/2011 - 01/2010
2Ascites
01/2022 - 05/2010
2Disease Progression
01/2022 - 07/2003
2Hemorrhage
01/2022 - 05/2010
2Hypertension (High Blood Pressure)
04/2019 - 01/2018
2Diabetes Mellitus
01/2018 - 08/2007
2Chronic Disease (Chronic Diseases)
08/2015 - 04/2011
2Neutropenia
02/2013 - 01/2012
2Body Weight (Weight, Body)
08/2011 - 06/2004
2Fatty Liver
11/2010 - 06/2006
2Vasculitis (Vasculitides)
02/2008 - 06/2006
2Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2008 - 08/2007
2Liver Failure
06/2005 - 07/2004
2HIV Infections (HIV Infection)
12/2002 - 02/2002

Drug/Important Bio-Agent (IBA)

73Ribavirin (Virazole)FDA LinkGeneric
10/2020 - 01/2002
65InterferonsIBA
01/2021 - 01/2002
47Hepatitis B e AntigensIBA
08/2023 - 01/2002
47Antiviral Agents (Antivirals)IBA
01/2023 - 02/2003
31Hepatitis B Surface Antigens (HBsAg)FDA Link
04/2023 - 06/2005
29Tenofovir (Viread)FDA Link
08/2023 - 03/2007
28DNA (Deoxyribonucleic Acid)IBA
04/2023 - 02/2003
21RNA (Ribonucleic Acid)IBA
04/2023 - 10/2002
18peginterferon alfa-2a (Pegasys)FDA Link
01/2020 - 02/2004
18Alanine Transaminase (SGPT)IBA
07/2017 - 10/2002
14Lamivudine (Epivir)FDA Link
01/2012 - 01/2002
13Protease Inhibitors (Protease Inhibitor)IBA
04/2019 - 12/2010
13adefovir dipivoxil (Hepsera)FDA Link
03/2011 - 02/2003
11NucleosidesIBA
02/2014 - 07/2004
11Interferon-alpha (Interferon Alfa)IBA
11/2007 - 01/2002
10NucleotidesIBA
01/2020 - 02/2003
8AntigensIBA
04/2023 - 07/2004
8SofosbuvirIBA
10/2020 - 02/2014
8SimeprevirIBA
04/2019 - 01/2011
8telaprevirIBA
01/2015 - 02/2011
8N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
01/2015 - 03/2011
8adefovirIBA
04/2014 - 12/2005
6Biomarkers (Surrogate Marker)IBA
04/2023 - 11/2002
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2016 - 01/2002
5daclatasvirIBA
10/2020 - 02/2014
5entecavirFDA Link
09/2016 - 03/2007
5danoprevirIBA
10/2013 - 12/2010
5CytokinesIBA
01/2012 - 01/2002
4tenofovir alafenamideIBA
08/2023 - 11/2016
4sofosbuvir drug combination ledipasvirIBA
08/2015 - 05/2014
4TelbivudineFDA Link
01/2015 - 03/2007
4Proteins (Proteins, Gene)FDA Link
10/2010 - 06/2006
3BilirubinIBA
01/2022 - 05/2016
3MicroRNAs (MicroRNA)IBA
10/2016 - 11/2012
3F 4 (F-4)IBA
11/2015 - 02/2006
3ledipasvirIBA
08/2015 - 05/2014
3Interferon alpha-2 (Roferon-A)FDA Link
08/2014 - 02/2004
3Emtricitabine (Emtriva)FDA Link
04/2014 - 03/2007
3ErythropoietinFDA Link
09/2013 - 08/2007
3Messenger RNA (mRNA)IBA
10/2010 - 02/2005
3clevudineIBA
12/2008 - 07/2004
3Transforming Growth Factor beta (TGF-beta)IBA
03/2007 - 01/2002
2bulevirtideIBA
01/2021 - 01/2021
2Viral RNAIBA
01/2021 - 06/2011
2Viral DNAIBA
07/2017 - 11/2010
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2016 - 02/2006
2asunaprevirIBA
11/2014 - 02/2014
2faldaprevirIBA
02/2014 - 02/2014
2InterleukinsIBA
02/2014 - 03/2012
2Circular DNAIBA
02/2014 - 06/2004
2Transaminases (Aminotransferases)IBA
12/2013 - 11/2002
2gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
08/2011 - 06/2006
2lipoarabinomannan (LAM)IBA
05/2010 - 03/2009
2Interferon-alpha2bIBA
01/2010 - 09/2006
2Interleukin-8 (Interleukin 8)IBA
09/2008 - 03/2007
2CryoglobulinsIBA
02/2008 - 06/2006
2AntibodiesIBA
11/2007 - 10/2007
2Triglycerides (Triacylglycerol)IBA
08/2007 - 08/2007
2peginterferon alfa-2b (Pegintron)FDA Link
04/2007 - 06/2004

Therapy/Procedure

93Therapeutics
01/2023 - 01/2002
11Liver Transplantation
04/2019 - 08/2002
5Transplantation
01/2018 - 08/2002
4Aftercare (After-Treatment)
01/2021 - 09/2008
4Duration of Therapy
02/2014 - 03/2004
4Retreatment
06/2012 - 04/2007
2Subcutaneous Injections
01/2021 - 08/2014